Database: NCZI Cancer Registry (Slovakia): Difference between revisions

Revision as of 14:04, 23 May 2024

Go back to Slovakia page

Primary purpose: To provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.

Sponsor, manager or home institution: Národné centrum zdravotníckych informácií.

Type of information: No data dictionary was found for this database.

Available type of information: Estimated cancer incidence and incidence indicators according to diagnosis; sex; year; age group; region and tumor staging. Click here to learn more.

Source of Information: Data reported by relevant intelligence units (SJ) and healthcare providers (PZS) who are obligated to report patients with malignant tumors.

Data level: patient level.

Available data level: regional level.

Number of records: unknown.

Date range: 1997 to 2012.

Cancer areas of interest:C00-C97: All cancer types and D00-D09: Early-stage cancers not yet spread. [%22M%22,%22rok-od%22:1997,%22rok-do%22:2012,%22uzemne-clenenie%22:%22Slovensko%22,%22uzemie%22:[%22Slovensko%22],%22diagnoza%22:[%22SPOLU%22]} Click here to learn more].

Data access: partially publicly available. Click here to access. Instructions to request data for restricted content click here to access.

Contact information: Click here to access.

@@ Line 1: / Line 1: @@
 Go back to [[Slovakia]] page
 {{forresearchers}}
+'''Primary purpose:''' To provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.
 '''Sponsor, manager or home institution:''' [[dataOwner::Národné centrum zdravotníckych informácií]].
-'''Primary purpose:''' To provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.
 '''Type of information:''' No data dictionary was found for this database.
-'''Available type of information:''' Estimated [[availableVariable:: cancer incidence]] and incidence indicators according to [[availableVariable::diagnosis]]; [[availableVariable::sex]]; [[availableVariable::year]]; [[availableVariable::age]] group; [[availableVariable::region]] and [[availableVariable::tumor staging]] [https://iszi.nczisk.sk/nor.sr/incidencia].
+'''Available type of information:''' Estimated [[availableVariable:: cancer incidence]] and incidence indicators according to [[availableVariable::diagnosis]]; [[availableVariable::sex]]; [[availableVariable::year]]; [[availableVariable::age]] group; [[availableVariable::region]] and [[availableVariable::tumor staging]]. [https://iszi.nczisk.sk/nor.sr/incidencia Click here to learn more].
 '''Source of Information:''' Data reported by relevant intelligence units (SJ) and healthcare providers (PZS) who are obligated to report patients with malignant tumors.
@@ Line 16: / Line 16: @@
 '''Available data level:''' [[availableDataLevel::regional level]].
-'''Number of Records:''' [[numberRecords::unknown]].
+'''Number of records:''' [[numberRecords::unknown]].
-'''Date Range:''' [[dataStart::1997]] [[dataEnd::2012]].
+'''Date range:''' [[dataStart::1997]] to [[dataEnd::2012]].
-'''Cancer Areas of Interest:''' [[hasCancerAreasList::malignant tumors and carcinomas in situ (C00-C96, D00-D09)]]; Lips, oral cavity and pharynx (C00 – C14); digestive organs (C15 – C26); Respiratory and intrathoracic organs (C30 – C39); Bones and articular cartilage (C40 – C41); Melanoma and other skin cancers (C43 – C44); Mesothelium and soft tissue (C45 – C49); Breast (C50); Female genital organs (C51 – C58); Male genitalia (C60 – C63); Urinary system (C64 – C68); Eye, brain and other parts of the CNS (C69 – C72); Thyroid and other endocrine glands (C73-C75); Imprecisely determined, secondary and non-specific locations (C76 – C80); Lymphatic, hematopoietic and related tissue (C81 – C96); Carcinomas in situ (D00 – D09).
+'''Cancer areas of interest:'''[[hasCancerType::C00-C97: All cancer types]] and [[hasCancerType::D00-D09: Early-stage cancers not yet spread]]. [https://iszi.nczisk.sk/nor.sr/incidencia/vyvoj/1997-2012/diagnozy?filter={%22ukazovatel%22:%22abs%22,%22pohlavie%22:[%22M%22],%22rok-od%22:1997,%22rok-do%22:2012,%22uzemne-clenenie%22:%22Slovensko%22,%22uzemie%22:[%22Slovensko%22],%22diagnoza%22:[%22SPOLU%22]} Click here to learn more].
-'''Data access:''' [[dataAvailability::partially publicly available]] [https://iszi.nczisk.sk/nor.sr/uvod]. Instructions to request data for restricted content [[hasDataAccessInstructions::[https://iszi.nczisk.sk/nor.sr/kontakt]]].
+'''Data access:''' [[dataAvailability::partially publicly available]]. [https://iszi.nczisk.sk/nor.sr/uvod Click here to access]. Instructions to request data for restricted content [[hasDataAccessInstructions::[https://iszi.nczisk.sk/nor.sr/kontakt click here to access]]].
-'''Contact information:''' Information [https://iszi.nczisk.sk/nor.sr/kontakt].
+'''Contact information:''' [https://iszi.nczisk.sk/nor.sr/kontakt Click here to access].